| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 29.59B | 43.43B | 23.00B | 8.40B | 12.95B |
| Gross Profit | 16.14B | 25.54B | 11.61B | -779.32M | 3.43B |
| EBITDA | 13.36B | 12.62B | 9.99B | -1.16B | 3.47B |
| Net Income | 10.67B | 8.76B | 6.83B | -3.43B | 1.33B |
Balance Sheet | |||||
| Total Assets | 99.84B | 94.58B | 87.22B | 80.96B | 85.24B |
| Cash, Cash Equivalents and Short-Term Investments | 16.92B | 22.42B | 17.15B | 16.35B | 21.44B |
| Total Debt | 2.61B | 4.85B | 2.16B | 8.06B | 6.97B |
| Total Liabilities | 16.21B | 18.19B | 16.00B | 16.50B | 16.17B |
| Stockholders Equity | 83.14B | 75.95B | 70.76B | 63.91B | 68.42B |
Cash Flow | |||||
| Free Cash Flow | 10.78B | 6.72B | 5.63B | -8.04B | -10.39B |
| Operating Cash Flow | 14.25B | 11.55B | 11.59B | -2.98B | -3.49B |
| Investing Cash Flow | -10.33B | -4.75B | -10.67B | 3.04B | 4.58B |
| Financing Cash Flow | -8.15B | -1.98B | -7.81B | -155.89M | -2.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$146.81B | 15.71 | 13.12% | 3.06% | 9.63% | 21.77% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$43.66B | 9.82 | 194.66% | 5.73% | 10.97% | 10.35% | |
61 Neutral | HK$29.79B | 19.06 | -11.87% | 5.92% | -1.98% | -49.13% | |
52 Neutral | HK$132.97B | 22.71 | 71.16% | 2.39% | 4.17% | -14.33% | |
45 Neutral | HK$9.53B | 3.36 | 73.50% | ― | 11.58% | ― | |
43 Neutral | HK$14.77B | -39.90 | -3.15% | ― | -3.01% | -15200.00% |